The effects of breastfeeding on serum asymmetric dimethylarginine levels and body composition in children.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25358091)

Published in Breastfeed Med on October 30, 2014

Authors

Renata Roszkowska1, Katarzyna Taranta-Janusz, Edyta Tenderenda-Banasiuk, Anna Wasilewska

Author Affiliations

1: Department of Pediatrics and Nephrology, Medical University of Białystok , Białystok, Poland .

Articles cited by this

Breast feeding and obesity: cross sectional study. BMJ (1999) 3.42

Measuring body composition. Arch Dis Child (2006) 2.54

Lifespan: catch-up growth and obesity in male mice. Nature (2004) 2.27

Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr (2009) 2.23

Infant-feeding patterns and cardiovascular risk factors in young adulthood: data from five cohorts in low- and middle-income countries. Int J Epidemiol (2010) 2.10

Food, growth, and time. Lancet (1962) 1.90

Feeding effects on growth during infancy. J Pediatr (2004) 1.85

Defining obesity risk status in the general childhood population: which cut-offs should we use? Int J Pediatr Obes (2010) 1.70

Is slower early growth beneficial for long-term cardiovascular health? Circulation (2004) 1.62

The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol (2000) 1.56

Breastfeeding, introduction of complementary foods, and adiposity at 5 y of age. Am J Clin Nutr (2006) 1.40

Infant feeding mode affects early growth and body composition. Pediatrics (2000) 1.38

Infant feeding method and obesity: body mass index and dual-energy X-ray absorptiometry measurements at 9-10 y of age from the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr (2007) 1.30

The height-, weight-, and BMI-for-age of Polish school-aged children and adolescents relative to international and local growth references. BMC Public Health (2010) 1.23

Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism (2004) 1.10

Asymmetric dimethylarginine, endothelial dysfunction and renal disease. Int J Mol Sci (2012) 0.99

Breast feeding is related to C reactive protein concentration in adult women. J Epidemiol Community Health (2006) 0.98

Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide (2011) 0.96

Breast feeding and cardiovascular disease risk factors, incidence, and mortality: the Caerphilly study. J Epidemiol Community Health (2005) 0.95

Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab (2004) 0.94

The effect of breastfeeding on cardiorespiratory risk factors in adult life. Pediatrics (2007) 0.91

Metabolic effects of different protein intakes after short term undernutrition in artificially reared infant rats. Early Hum Dev (2008) 0.91

C-reactive protein (CRP) gene polymorphisms: implication in CRP plasma levels and susceptibility to acute myocardial infarction. Mol Biol Rep (2011) 0.87

Infant diet and subcutaneous fat mass in early childhood: the Generation R Study. Eur J Clin Nutr (2011) 0.86

High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction. PLoS One (2013) 0.83

Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2011) 0.83

[Childhood diet and cardiovascular risk factors]. Arch Pediatr (2009) 0.81

The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol (2011) 0.81

Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine. Early Hum Dev (2014) 0.78

HEALTH IN ADOLESCENCE. Practitioner (1963) 0.77

Articles by these authors

Hematological parameters in adolescents with hyperuricemia. Indian Pediatr (2014) 2.00

Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr (2012) 1.48

Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr (2010) 1.40

KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23

Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int (2013) 1.21

Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11

Perception of health-related quality of life in children with chronic kidney disease by the patients and their caregivers: multicentre national study results. Qual Life Res (2013) 0.94

A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92

Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89

Perivascular epithelioid tumor (PEComa) of the falciform/ broad ligament. Pol J Pathol (2008) 0.87

Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86

Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol (2012) 0.84

Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol (2014) 0.83

Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81

Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81

Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.81

Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81

Urinary angiotensinogen as a novel marker of obstructive nephropathy in children. Acta Paediatr (2013) 0.80

Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80

Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2014) 0.79

Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr (2012) 0.79

Epidemiological study of acute poisoning in children: a 5-year retrospective study in the Paediatric University Hospital in Białystok, Poland. Emerg Med J (2012) 0.79

Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79

Paediatric normative data for urine NGAL/creatinine ratio. Acta Paediatr (2013) 0.78

Psychosocial aspects of children and families of children treated with automated peritoneal dialysis. Pediatr Nephrol (2013) 0.78

Mutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian population. J Appl Genet (2013) 0.78

Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78

Serum 25-hydroxyvitamin D, osteocalcin, and parathormone status in children with meningomyelocele. Neuropediatrics (2012) 0.77

Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Pediatr Nephrol (2013) 0.77

[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77

Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol (2013) 0.77

Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele. Scand J Urol (2013) 0.77

Is symmetric dimethylarginine a sensitive biomarker of subclinical kidney injury in children born with low birth weight? Biomarkers (2014) 0.76

Urine fibroblast growth factor 23 levels in hypertensive children and adolescents. Croat Med J (2015) 0.76

Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76

Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76

[FGF23 and Klotho protein--the role in the pathogenesis of hypertension]. Wiad Lek (2015) 0.76

Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers (2013) 0.75

Evaluation of Serum Uric Acid: Authors' Reply. Indian Pediatr (2015) 0.75

Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75

Anxiety in children and adolescents with chronic kidney disease--multicenter national study results. Kidney Blood Press Res (2013) 0.75

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population? Pediatr Nephrol (2014) 0.75

Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75

Normal values for urine renalase excretion in children. Pediatr Nephrol (2014) 0.75

New tubular injury markers in children with a solitary functioning kidney. Pediatr Nephrol (2014) 0.75

[Urinary TGF-beta1 excretion in children with renal cysts]. Przegl Lek (2006) 0.75

[Urinary laminin and fibronectin level in children with nephritic syndrome]. Pol Merkur Lekarski (2009) 0.75

[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75

[Assessment of fructose-1,6-biphosphatase in urine of children with acute pyelonephritis]. Pol Merkur Lekarski (2004) 0.75

[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75

[The role of early-life metabolic programming in the pathogenesis of lifestyle diseases]. Dev Period Med (2015) 0.75

High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75

Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75

[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski (2008) 0.75

Erratum to: Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol (2015) 0.75

[Carriage of Streptococcus pneumoniae in nasopharynx in children with nephrotic syndrome aged 2-5 years in Poland]. Pol Merkur Lekarski (2008) 0.75

Increased circulating inflammatory markers may indicate that formula-fed children are at risk of atherosclerosis. Acta Paediatr (2014) 0.75

[Serum cystatin C concentration in children with urinary stones]. Pol Merkur Lekarski (2006) 0.75

[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75

Primary soft tissue giant cell tumour of the neck. Cytological and histological characteristics of the tumour and differential diagnosis. Pol J Pathol (2009) 0.75

Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75

Round Table Discussion. Ann Nutr Metab (2016) 0.75

[Differences in dietary habits and food preferences of adults depending on the age]. Rocz Panstw Zakl Hig (2012) 0.75

Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele. Urol Int (2015) 0.75

[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75

[Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schonlein-Henoch purpura]. Pol Merkur Lekarski (2002) 0.75

[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75